KoBioLabs, Inc (KOSDAQ:348150)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,780.00
+170.00 (4.71%)
At close: Jun 5, 2026

KoBioLabs Revenue

KoBioLabs had revenue of 19.22B KRW in the quarter ending March 31, 2026, with 11.10% growth. This brings the company's revenue in the last twelve months to 71.21B, up 0.61% year-over-year. In the year 2025, KoBioLabs had annual revenue of 69.29B with 1.36% growth.

Revenue (ttm)
71.21B
Revenue Growth
+0.61%
P/S Ratio
1.03
Revenue / Employee
n/a
Employees
n/a
Market Cap
73.40B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202569.29B932.96M1.36%
Dec 31, 202468.36B35.22B106.28%
Dec 31, 202333.14B21.53B185.54%
Dec 31, 202211.61B8.71B301.12%
Dec 31, 20212.89B-1.70B-36.98%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
CTCBIO128.76B
Naturalendo Tech21.69B
BIO-FD&C18.85B
Ark Solutions17.95B
PanGen Biotech13.71B
TegoScience5.83B
EyeGene4.02B
SunBio,Inc.2.17B
Revenue Rankings